Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors

NCT04657562 is registered in ClinicalTrials.gov with National Science Centre, Poland as lead sponsor.

NCT NCT04657562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04657562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors
Lead sponsor
National Science Centre, Poland
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2020
Completion date
May 31, 2023
Enrollment
380 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic predisposition, immunosuppression, kidney transplant rejection, kidney transplant; complications, liver transplant rejection, liver transplant; complications, metabolism medication toxicity